The purpose of this commentary is to critically examine the CREST-2 results, discuss their implications for clinical decision-making for asymptomatic carotid artery disease, and guide clinicians ...

Delcath Systems, Inc. announced the publication of a retrospective study reporting outcomes from patients with liver-dominant ...

In a retrospective study evaluating circulating fatty acid synthase (cFAS) as a biomarker for peripheral artery disease (PAD) ...

Solaris Endovascular announced 12-month results from the Solaris SX iliac postmarket clinical follow-up study of the ...

Rampart IC, a developer of radiation shielding for interventional suites, announced new data on the reduction in radiation ...

Angiolutions announced that the first patient has been treated in a first-in-human (FIH) study evaluating the safety and ...

Bentley InnoMed GmbH, which is headquartered in Hechingen, Germany, announced the first-in-human use of the company’s BeG ...

Penumbra Inc. announced it has secured CE Mark approval for its Lightning Bolt 12 and Lightning Bolt 6X with Trax. These next-g ...

Akura Medical, a Shifamed portfolio company focused on venous thromboembolism care, announced it has secured a $53 million firs ...

Royal Philips announced the expanded commercial availability of its LumiGuide device guidance across Europe and the United Stat ...

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.